Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biofrontera Inc. Director's Dealing 2025

Sep 17, 2025

35198_dirs_2025-09-16_0734954e-139a-48de-b0b5-de95f75ff4cb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Biofrontera Inc. (BFRI)
CIK: 0001858685
Period of Report: 2025-08-25

Reporting Person: Jones George Patrick (Chief Commercial Officer)